Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
22
NMPA:22
Drug Approvals
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20249830
- Approval Date
- Dec 25, 2024
NMPA
Metoclopramide Hydrochloride Injection
- Product Name
- 盐酸甲氧氯普胺注射液
- Approval Number
- 国药准字H20249637
- Approval Date
- Dec 1, 2024
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20249399
- Approval Date
- Nov 15, 2024
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20249400
- Approval Date
- Nov 15, 2024
NMPA
Aripiprazole Oral Solution
- Product Name
- 阿立哌唑口服溶液
- Approval Number
- 国药准字H20243306
- Approval Date
- Jul 23, 2024
NMPA
Fudosteine Oral Solution
- Product Name
- 福多司坦口服溶液
- Approval Number
- 国药准字H20247145
- Approval Date
- Jun 28, 2024
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20244070
- Approval Date
- Jun 18, 2024
NMPA
Potassium Chloride Granules
- Product Name
- 氯化钾颗粒
- Approval Number
- 国药准字H20244069
- Approval Date
- Jun 18, 2024
NMPA
Levocarnitine Oral Solution
- Product Name
- 左卡尼汀口服溶液
- Approval Number
- 国药准字H20244005
- Approval Date
- Jun 11, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found